GoodRx, drug discount cards impacting pharmacy margins - BoA
shapecharge/iStock via Getty Images

The rise in the use of prescription drug discount cards from companies such as GoodRx (NASDAQ:GDRX) is negatively impacting margins for pharmacy chains, according to Bank of America.
As a result, pharmacy benefit managers are benefitting at the expense of retail pharmacies, said BoA analyst Allen Lutz.

GoodRx (GDRX) has partnered with several PBMs this year including CVS Health's (CVS) Caremark and MedImpact.
These partnership could "further accelerate the recent decline of high-margin cash pay prescriptions for pharmacies," Lutz wrote.
He added that CVS (CVS) is in a better position than Walgreens Boots Alliance (WBA) as Caremark "can capture fees related to these new agreements while Walgreens (WBA) cannot."


More on GoodRx Holdings

GoodRx Holdings: Stay Cautious In FY23 Until Clear Signs Of Growth Inflection Appear
TD Cowen upgrades GoodRx on game-changing PBM partnerships; stock soars
Seeking Alpha's Quant Rating on GoodRx Holdings